← Back to Search

telehealth advance care planning for Dementia

N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will help create better resources for advanced care planning for families with dementia.

Eligible Conditions
  • Dementia
  • Advanced Care Planning

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptibility of Decision Aid Tool
Feasibility of Information Sheet among Study Population
Secondary outcome measures
Adaptation of Advance Care Planning Engagement Survey
Adaptation of Advance Care Planning Engagement for Surrogates Survey
Decision Self-efficacy Scale
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
One time receipt and review of an information sheet
Group II: Non-InterventionActive Control1 Intervention
Usual care will be delivered per standards of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
telehealth advance care planning
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
979 Previous Clinical Trials
7,386,448 Total Patients Enrolled
12 Trials studying Dementia
1,252 Patients Enrolled for Dementia
University of PennsylvaniaOTHER
2,015 Previous Clinical Trials
42,874,013 Total Patients Enrolled
18 Trials studying Dementia
36,807 Patients Enrolled for Dementia
~5 spots leftby Jun 2025